MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects

HaEun Kim1,2, Benjamin Lebeau1,2,3, David Papadopoli2,4

  • 1Department of Experimental Medicine, McGill University, Montreal, QC H3A 0G4, Canada.

Iscience
|March 4, 2024
PubMed

Insights

Mechanistic target of rapamycin (mTOR) pathway activation or inhibition selectively increases H3K27me3 histone modification. This epigenetic change, mediated by distinct mechanisms, may enhance the anti-proliferative effects of mTOR inhibitors.

Area of Science:

  • Cellular Biology
  • Epigenetics
  • Molecular Biology

Background:

  • Metabolic and epigenetic programs exhibit significant cross-talk.
  • The mechanistic target of rapamycin (mTOR) pathway is a key metabolic regulator.
  • The precise relationship between mTOR signaling and epigenetic modifications is not well understood.

Purpose of the Study:

  • To investigate the impact of mTOR pathway modulation on specific histone modifications.
  • To elucidate the mechanisms underlying changes in histone methylation.
  • To explore the correlation between mTOR-induced epigenetic changes and anti-proliferative effects.

Main Methods:

  • Analysis of histone modifications (H3K27me3, H3K4me3, H3K9me3) in response to mTORC1 activation (TSC2 abrogation) and inhibition.
  • Assessment of EZH2 and EZH1 protein levels.
  • Correlation analysis between H3K27me3 induction and anti-proliferative activity of mTOR inhibitors.

Main Results:

  • mTORC1 activation selectively increased H3K27me3 levels, independent of H3K4me3 and H3K9me3, via increased EZH2.
  • mTOR inhibition also selectively induced H3K27me3 through a mechanism involving reduced EZH2 and increased EZH1.
  • The induction of H3K27me3 by mTOR inhibitors correlated positively with their anti-proliferative effects.

Conclusions:

  • Both activation and inhibition of the mTOR pathway selectively increase H3K27me3 via distinct molecular mechanisms.
  • The selective induction of H3K27me3 may contribute to the anti-proliferative efficacy of mTOR inhibitors.
  • This study reveals a novel link between mTOR signaling and H3K27 trimethylation dynamics.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K